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The Science and Technological Innovation System in Cuba is overseen by the Ministry of Science, Technology and the Environment (CITMA), in accordance with Resolution No. 44/2012, which resulted in the reorganization of scientific activity based on a policy aimed at achieving greater efficiency and closer ties with productive and service activities (1) . Consequently, the number of research programs and structures was reduced, and they were renamed and classified according to their mission as follows (2):
• Research centers, when their main activity is scientific research and innovation;
• Science and technology service centers, in charge of service delivery, specialized production and research; • Development and innovation units, organized as enterprises, 6 budgeted units (funded by the State) or other types of organization, all of which are mandated to develop or innovate in order to add value to the goods, services and processes they offer.
Research and development activities are organized on the basis of programs and projects (basic research unit), and are classified as follows (1):
• Projects associated with science, technology and innovation programs designed to study problems of national interest, supervised by CITMA regardless of sector; programs group together interrelated projects to fulfill State priorities; management units in the health sector are responsible for health-related programs • Projects not associated with programs, aimed at resolving national priorities that do not require implementation of a program • Institutional projects, which conduct research on priorities identified by non-entrepreneurial entities for solving concrete problems • Entrepreneurial projects, which aim to solve priority problems specific to enterprises or business groups Approximately 26% of all Cuban scientific institutions are dedicated to health-related research, development and innovation, and are part of the Ministry of Public Health (MINSAP), the Biotechnology and Pharmaceutical Industry Group (BioCubaFarma), universities and other sectors (4) . MINSAP sets the sector's priorities in accordance with the country's economic and social policy guidelines (5) .
The State provides funding to carry out research, innovation and development programs and projects at all levels. In 2016, 35 .4% of the total national science and technology budget was allocated to science and technology in the health sector (6) . Other funding sources include businesses, bank loans, international agencies, nongovernmental organizations, donations and cooperative agreements with other countries (1) . 6 A state enterprise is an entity with it own legal status, created to produce goods and services through efficient administration of financial, material and human resources. It is considered a fundamental link in the economy.
In the 2013 World Health Report, the Director-General of the World Health Organization (WHO) stated, "All countries must be producers as well as consumers of research. (7) .
Cuba has systematically worked toward that goal. The Science and Technological Innovation System for Health (SCITS) is singular and all-inclusive, and guided by two principles: the interdependence of education, services and research; and the integration of scientific advances into social practice (8) . This approach enables the study of health problems and needs at the three levels of care (primary, secondary and tertiary) with alternative solutions in accordance with a sectoral, intersectoral, multidisciplinary perspective and adherence to local culture (9) .
SCITS' present development is due to the government's commitment and priority attention given to research, innovation and development of products and services to meet the population's health needs. Consequently, conditions, resources and human capital formation are guaranteed so that actions developed in SCITS programs and projects contribute to efficiency, equity and the well-being of the population (10) .
The purpose of this article is to describe the features of SCITS in Cuba and present research results that illustrate its positive effect on the population's health.
CUBA'S SCIENCE AND TECHNOLOGICAL INNOVATION SYSTEM IN HEALTH
SCITS comprises 37 science and technological innovation institutions: 16 research centers, 3 science and technology service centers, and 18 development and innovation units administered by MINSAP with methodological oversight by CITMA. Scientific societies contribute to its functioning as do other organizations involved with technological innovation for import substitution (e.g., the National Association for Innovation and Rationalization, the Youth Technical Brigades, and the Science and Technical Forum). This system employs more than 20 000 workers in different occupational categories (Table 1 ). In addition to research, these centers offer undergraduate and graduate courses, and provide specialized services to the public. In line with CITMA's policy, MINSAP analyzed the situation of science and set research priorities for 2012-2016 in five national programs, based on changes in the population's health status, availability of resources and the need to optimize them (Table 2) , explained as follows (11):
Program 1: Health determinants, risks and disease prevention in vulnerable groups. Emergence of new economic actors and income disparities between different social groups-along with a demographic situation marked by low fertility and birth rates, population aging and migration-have imposed a new social/health context on the National Health System (SNS), in which certain social groups may be affected.
Program 2: Organization, efficiency and quality in health systems and services. Given the constraints imposed on Cuba's access to markets under favorable conditions (12) and the global economic crisis, the SNS has been obliged to prioritize and optimize organizational, quality and efficiency processes in order to maintain the sustainability of current services, based on their design and realities.
Program 3: Natural and traditional medicine. The program attempts to preserve culture in health care through integration of traditional and modern natural medicine techniques.
Program 4: Cancer. Cancer is the second-leading cause of death in Cuba. This group of diseases causes approximately 18 and 19 years of potential life lost in women and men, respectively (13) . Research focuses on improving prevention, diagnosis, comprehensive care and rehabilitation.
Program 5: Aging, longevity and health. Individuals aged ≥60 years account for 19% of the population, and the indicator is trending upward (13) , signifying a greater burden on social and health services; research should contribute to attainment of healthy aging.
By the end of 2016, more than 2 000 research projects were underway, mostly in primary and secondary health care institutions; 401 of the studies in the five national programs were more closely linked to the tertiary level and to institutions in Havana, the country's capital. The results helped identify new research priorities for 2017, such as premature mortality and accidents; the need for further research in basic sciences and stateof-the-art medicine (robotics, computer science, nanotechnology); evaluation of health technologies; and accreditation of quality in health institutions. 7 The health research process in Cuba follows universal tenets: starting with a problem-and taking into account the socioeconomic environment, health conditions, societal principles and values-a scientific idea is identified; the problem and method are defined; the project is designed and carried out; and the results are evaluated for subsequent introduction and generalization in social practice until the intervention concludes with new questions (14) ( Figure 1 ).
The ethical conduct and methodological rigor of the research are the responsibility of the researchers, principal investigators and institutional directors, advised by scientific councils and 7 Morales I. Science Day inaugural speech, Havana, 15 January 2017. research ethics committees (1, 2) . At the national level, the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) is responsible for ensuring safety and compliance with ethical regulations in individuals and communities.
Product-and service-related projects (medicines, technologies and programs) are conceived as closed-loop processes.
BioCubaFarma was created in 2012 (15, 16) as a senior management organization under the Council of Ministers, which integrates the research-development-production centers for biotechnology, the pharmaceutical industry and high-tech medical equipment. With 32 companies, 70 production facilities, 10 research centers, 11 research and development units, and one science and technology services center, BioCubaFarma employs 21 000 workers. It is also part of SCITS. Its objective is to ensure that the SNS has the essential medicines (biotechnology and generic), products, raw materials, vaccines, reagents, diagnostic tools and equipment it needs, in addition to its own lines of research (17, 18) (Table 3) .
BioCubaFarma is self-financed and conceives scientific research not only as a producer of knowledge but also as a source of material and financial resources for recouping investments without neglecting its social commitment to public health.
The Cuban population's access to high quality medical care is made possible by the integration of research centers with science and technology services delivery centers, development and innovation units, universities and health care 
Developing human capital
Scientific activity calls for highly qualified personnel committed to solving health problems (10) . Training for research begins in undergraduate education, is strengthened through work experience, and reaches the height of current knowledge and specialization in graduate education (in Cuba or abroad) up to the doctorate level (10, 19) .
Professional researchers are classified through a system that combines years of experience, professional level and outcomes with annual evaluations that show advances or setbacks in indicators measured individually and institutionally, such as participation in scientific projects and events; publications; dissertations directed; scientific honors and degrees awarded; and registration of patents, copyrights and introduction of results (19) .
At the end of 2016, MINSAP had 3 214 researchers classified as senior researchers (8.5%), associate researchers (21.7%), adjunct researchers (57.6%), and researcher candidates (12.2%).
During that year, 224 posts became vacant (due to migration, death or retirement); the analysis shows the lowest percentages of researchers in the senior researcher and candidate groups (20) .
Extending research to all health units has posed the challenge of a new "literacy" process (21) for appropriate use of scientific mechanisms and tools, given the need to address difficulties common to all SCITS in the Americas, for example: developing research competencies, achieving conscious and responsible participation of affected communities and other sectors, and validating results by increasing the number of publications and patents (22) .
Other challenges include access to funding and proper use of funds, technological obsolescence, facilities maintenance, researcher instability and aging, as well as the dismissive stance toward research and innovation taken by some decision makers (7, 22) .
EFFECTS OF RESEARCH ON THE POPULATION'S HEALTH
To illustrate the influence of Cuban SCITS research on health, several research-and-development examples have been selected for their demonstrated contribution to the study and control of priority health problems. These examples combine basic and applied research from biomedical, social and other science perspectives (Table 4) .
One example is the generation of health products (medicines, reagents, etc.) and technologies (equipment and systems), which are essential to lowering mortality from diseases in Cuba, primarily the four leading causes of death: heart disease (217.7 deaths per 100 000 population), malignant tumors (216.3 per 100 000 population), cerebrovascular diseases (84.2 per 100 000 population) and diabetes mellitus (20.0 per 100 000 population) (13) .
In addition, research on dengue and diabetes, and the biopsychosocial study of disability, span health systems and services, and have led to changes in medical practice, social policies, and specific educational and health care programs for vulnerable groups.
Generating health products and technologies
The first outcome of this type of research was the Ultramicroanalytical System (SUMA), which enables mass screening for several infectious diseases in the general population and in specific groups, such as pregnant women, blood donors, and human immunodeficiency virus (HIV) carriers (10) . By September 2014, more than 48 million SUMA tests had been administered to control transmission of HIV, hepatitis B and C, dengue, Chagas disease and Hansen disease (leprosy). More than 34 million tests had been administered to blood donors to control transmission of HIV and hepatitis B and C (23) .
In the framework of the National Maternal-Child Health Program, more than 4 million pregnant women had been tested by 2014. Prenatal detection of congenital defects through measuring alpha fetoprotein in maternal blood has given pregnant women and their partners the option to receive additional tests, genetic counseling, or selective and informed termination of pregnancy, since these techniques can confirm severe congenital fetal defects (24) . More than 7 million pregnant women and their partners have been tested to control for vertical transmission of HIV, syphilis and hepatitis B. As a result, Cuba was designated the first country in the world to eliminate mother-to-child transmission of HIV and congenital syphilis (25) . Today, this program covers the care of more than 95% of pregnant women in the country (24) .
Research has also spawned domestic production of 8 of the 11 vaccines that make up the National Immunization Program, which has achieved >98% coverage. Diseases such as tetanus, meningococcal meningitis, Haemophilus influenzae type b infection and typhoid fever have ceased to be a health problem in Cuba, while morbidity and mortality from hepatitis B have been reduced by more than 98% (26) .
In addition to preventive vaccines, biotechnology provides other products to 
Educating people with diabetes
Research and interventions by the National Endocrinology Institute on the knowledge, attitudes and practices of people with diabetes have been an essential pillar of the National Diabetes Care and Patient Education Program since it was implemented in 1981 (31) . The results have helped prevent complications and improve quality of life for diabetic patients, who have not needed to resort to new types of insulin or other technologies. Although Heberprot-P ® has been introduced as an effective treatment for diabetic foot ulcers (30) , research also showed that patients obtain maximum benefit from the product only with strict adherence to the program's therapeutic and hygienic norms.
Studies found that patients' increased knowledge and skills related to daily care (independent of age, education level, and type and duration of diabetes) were associated with a marked decline in average glycosylated hemoglobin (HbA 1 ) levels and reductions in dosages of medicines, frequency of excess body weight, and average number of hospitalizations due to decompensation (31, 32) .
The presentation and development of long-term complications in patients with recent onset of type-1 diabetes were also studied. Frequency of diabetic retinopathy was found to be significantly lower in the group monitored with an interactive methodology based on constructive dialogue between the person providing information and the one receiving it, compared with patients who received only individual counseling through traditional medical checkups. In the former group, concerns are listened to, skills are developed to manage different therapeutic demands, and efforts are made to develop motivation and self-confidence for confronting problems. Similar results were obtained when evaluating the evolution of nephropathy and peripheral neuropathy (31) .
All this does not minimize the magnitude of diabetes as a health problem. Working in the community with patients and the general population to prevent diabetes must, therefore, continue, emphasizing full compliance with medical, health and hygienic treatment (32) . Promoting the importance of personal responsibility in health continues to be fundamental (40) .
Dengue research
These studies reached their height in 1981 when Cuba suffered a lethal hemorrhagic dengue epidemic (41) . Initial efforts focused on the disease's epidemiology, on describing the clinical evolution of children who died from severe dengue, and on its warning signs, defined as "a group of signs and symptoms indicating the imminent onset of shock from dengue" (36) . These studies received recognition from the Pan American Health Organization (PAHO) and WHO as the guidelines for early detection of patients evolving toward severe dengue, who require a different type of treatment (33) (34) (35) . The prospective DEN-CO study (36) , which included more than 1 700 confirmed cases, showed that the classification based on warning signs and initially used in Cuba had 96% sensitivity and 100% specificity. As a result, it was incorporated into WHO policy documents and into guidelines in Cuba and other countries in the Region for comprehensive management of dengue patients.
The most important of these studies, led by the Pedro Kourí Tropical Medicine Institute, include establishment of the comprehensive hypothesis about hemorrhagic dengue (41) , virologic studies to describe the viruses causing the epidemics and outbreaks of dengue in Cuba, and virulence markers and their association with severe dengue. These studies have also benefited other countries in the Region.
Entomological studies and operations research on controlling the Aedes aegypti mosquito have identified and described the vector's main breeding sites and resistance mechanisms. BioCubaFarma and other centers are also working to obtain a candidate vaccine against the disease.
Research on socioeconomic determinants, and social and intersectoral participation, are also relevant, as well as studies of public knowledge, attitudes and practices. Despite measures taken by MINSAP and government support, at the end of 2016 some municipalities still had infestation indices 8 above the maximum level allowed for control of epidemics established in the National Aedes aegypti Eradication Program (0.05), which confirms the importance of socioeconomic determinants for controlling dengue. These investigations currently include the study of other arboviruses caused by the same vector (42) .
Biopsychosocial study of people with disabilities
Persons with disabilities constitute one of the most vulnerable sectors in any society; their study and care are a challenge in any country. In Cuba, the first comprehensive study of people with disabilities was designed and conducted in 2001-2003 (37) .
The study included 366 864 individuals with a disability (3.26% prevalence in the surveyed population). The highest rates were found in the provinces of Guantánamo (4.13%) and Santiago de Cuba (3.79%).
The survey detected 140 489 people (38.29%) with an intellectual disability, for a prevalence of 1.25%. Of those, 92 506 (25.2%) presented a physical-motor disability, for a prevalence of 0.82%; 46 455 (12.7%) had a visual disability (0.41% prevalence); 36 869 (10.1%) mental disability (0.33% prevalence); 23 620 (6.4%) auditory disorders (0.21% prevalence); 25 094 (6.8%) presented mixed disabilities (0.22% prevalence); and 1 831 (0.5%) were diagnosed with chronic kidney failure (0.02% prevalence) (37) .
The following disability programs are highlighted in the results of the study:
• Community-based programs: genetics, rehabilitation and social work; 8 Indicates the degree of infestation by the vector in the area surveyed, expressed as the percentage of dwellings and other sites that tested positive with respect to the total number inspected (42) . • Establishment of 23 lines of research on factors associated with disability; • Legal recognition of the condition of "caregiver mother," who receives a full salary for caring for her disabled child at home; • Technical and economic assistance, and free meals, provided to persons with disability.
In 2007-2010, the research was replicated in Venezuela, Ecuador, Nicaragua, Bolivia, and St. Vincent and the Grenadines, at the request of their governments (43) .
Final considerations
The research reviewed on each of the selected topics are examples of how solutions emerge from overlaps between different disciplines in the biomedical sciences, and that "progress is made not only by those who are most knowledgeable but by those who best combine their knowledge" (21) .
The results obtained are the product of a long and arduous process, involving political will, developing human capital, building a national industry, creating the material and financial operating conditions, and the need to resolve contradictions between epistemological positions and knowledge, or between managers and researchers ( Table 5 ).
CONCLUSIONS
SCITS in Cuba is sustained by a national policy that promotes science at all levels of health care and that has solved priority health problems. It faces challenges common to other countries in the region, such as access to funding, technological obsolescence and preservation of human capital, derived from constraints imposed on the economy and changes in the socioeconomic context.
The research presented offers important contributions that have been introduced into health practice in the form of policies, programs, products, technologies, and high quality social and health care services. These advances have provided coverage for the population in need and have had a positive effect on their health status. Even so, given their magnitude and complexity, these and other problems will continue to be objects of scientific study in the health sciences ad infinitum.
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TABLE 5. Lessons learned
Health research in Cuba and its application are a reality thanks to: • The political will of the State, which has provided funding, coordination and generation of synergies between health services, research centers, enterprises in different sectors and the disciplines, enabling a developing country to conduct research and introduce cutting-edge technologies to raise the health standards of its population. • Establishment of the Science and Technological Innovation System in Health (SCITS), since the State is committed to defining research and development priorities and to contributing contributes most of the resources. • SCITS' dynamism in adapting its priorities, organization and functioning to changing social and health needs. • The systematic care and formation of human capital, dialogue with decision-makers, methodological rigor, and researchers' ethics and social commitment needed in order for SCITS to meet its objectives.
RESUMEN
En Cuba, la investigación para la salud se basa en las prioridades de la política científica nacional, derivadas del estado de salud de la población. El objetivo de este artículo es describir las caracte rísticas del Sistema de Ciencia e Innovación Tecnológica en el sector y cómo los resultados de sus investigaciones benefician la salud de los grupos poblacionales. Para ello se seleccionaron inves tigaciones relacionadas con la generación de productos y tecnologías, la diabetes, el dengue y la discapacidad. Este sistema sigue los preceptos metodológicos del Ministerio de Ciencia, Tecnología y Medio Ambiente y cuenta con 37 entidades de investigación. Se organiza en programas y proyectos que favorecen la investigación básica y aplicada, con un enfoque multidisciplinario e inter sectorial; estos son financiados mayormente por el Estado y organizados en ciclos cerrados o completos, es decir, una misma entidad se encarga de todo el proceso, desde la investigación hasta la comercialización, incluidos los estudios de mercados y la vigilancia poscomercialización. Las investigaciones seleccionadas evidencian la armonía entre la investigación, la generalización de los resultados y su efecto en mejorar la salud y el acceso universal de la población. Se lograron resultados en métodos de diagnóstico, vacunas preventivas y terapéuticas, signos de alarma para el pronóstico y tratamiento del dengue, prevención de malformaciones congénitas, y políticas y programas que han beneficiado a las personas con discapacidad y sus familiares. La voluntad del Estado para desarrollar y financiar la investigación científica, la acción intersectorial, la defini ción de las prioridades de investigación, y la preparación y atención sistemática del capital humano han sido factores determinantes para el cumplimiento de los objetivos del sistema.
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Ciencia e innovación tecnológica en la salud en
Cuba: resultados en problemas seleccionados RESUMO Em Cuba, a pesquisa em saúde baseia-se nas prioridades da política científica nacional, derivadas do estado de saúde da população. O objetivo deste artigo é descrever as características do Sistema de Ciência e Inovação Tecnológica e como os resultados de suas pesquisas beneficiam a saúde dos grupos populacionais. Para este fim, foram sele cionadas pesquisas relacionadas à geração de produtos e tecnologias, diabetes, dengue e deficiência. Este sistema segue a metodologia do Ministério da Ciência, Tecnologia e Meio Ambiente e possui 37 entidades de pesquisa. Está organizado em programas e projetos que favorecem pesquisas básicas e aplicadas, com abordagem multidisciplinar e intersetorial; estes são financiados principalmente pelo Estado e organizados em ciclos fechados ou completos, ou seja, a mesma entidade é responsável por todo o processo, desde pesquisa até marketing, incluindo estudos de mercado e vigilância pós-comercialização. As pesquisas selecionadas mostram a harmonia entre a pesquisa, a generalização dos resultados e seus efeitos na melhoria da saúde e no acesso univer sal à saúde na população. Resultados positivos foram obtidos em métodos de diagnós tico, vacinas preventivas e terapêuticas, sinais de alerta para o prognóstico e trata mento da dengue, prevenção de malformações congênitas e políticas e programas que beneficiaram pessoas com deficiência e suas famílias. A vontade do Estado de desen volver e financiar pesquisas científicas, ações intersetoriais, a definição de prioridades de pesquisa e o treinamento e atenção sistemática do capital humano têm sido fatores determinantes para o cumprimento dos objetivos do sistema.
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